496 related articles for article (PubMed ID: 6280770)
21. Cyclic nucleotide phosphodiesterase. Partial purification and characterization of a high affinity enzyme activity from human lung tissue.
Bergstrand H; Lundquist B; Schurmann A
J Biol Chem; 1978 Mar; 253(6):1881-91. PubMed ID: 204635
[TBL] [Abstract][Full Text] [Related]
22. Protein activator of cyclic AMP phosphodiesterase and cyclic nucleotide phosphodiesterase in bovine retina and bovine lens. Activity, subcellular distribution and kinetic parameters.
Liu YP; Schwartz HS
Biochim Biophys Acta; 1978 Sep; 526(1):186-93. PubMed ID: 210826
[TBL] [Abstract][Full Text] [Related]
23. Effects of divalent metals on the specificity of inhibitors of the cyclic nucleotide phosphodiesterases from bovine heart.
Donnelly TE; Barron B
Biochim Biophys Acta; 1981 Jan; 657(1):168-78. PubMed ID: 6260197
[TBL] [Abstract][Full Text] [Related]
24. Effect of trifluoperazine on cyclic nucleotide phosphodiesterase activity in crude homogenates of bovine adrenal medulla.
Crimaldi AA; Kuo IC; Coffee CJ
Ann N Y Acad Sci; 1980; 356():367-8. PubMed ID: 6263155
[No Abstract] [Full Text] [Related]
25. Calmodulin-dependent high-affinity cyclic AMP phosphodiesterase in liver membranes.
Smoake JA; Johnson LS; Peake GT
Arch Biochem Biophys; 1981 Feb; 206(2):331-5. PubMed ID: 6261695
[No Abstract] [Full Text] [Related]
26. Properties of multiple kinetic forms of soluble cyclic nucleotide phosphodiesterase activity of rat colonic mucosa.
Craven PA; Neidig M; DeRubertis FR
Biochim Biophys Acta; 1983 May; 744(3):265-75. PubMed ID: 6303428
[TBL] [Abstract][Full Text] [Related]
27. A comparative kinetic study of bovine calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes utilizing cAMP, cGMP and their 2'-O-anthraniloyl-,2'-O-(N-methylanthraniloyl)-derivatives as substrates.
Grewal J; Karuppiah N; Mutus B
Biochem Int; 1989 Dec; 19(6):1287-95. PubMed ID: 2561449
[TBL] [Abstract][Full Text] [Related]
28. Phosphodiesterase activities for cyclic nucleotides in nerve endings from the bovine posterior pituitary gland.
Vale MR; Baker RV; Hope DB
J Neurochem; 1984 Feb; 42(2):377-83. PubMed ID: 6319599
[TBL] [Abstract][Full Text] [Related]
29. Function of calmodulin in postsynaptic densities. I. Presence of a calmodulin-activatable cyclic nucleotide phosphodiesterase activity.
Grab DJ; Carlin RK; Siekevitz P
J Cell Biol; 1981 Jun; 89(3):433-9. PubMed ID: 6265466
[TBL] [Abstract][Full Text] [Related]
30. Evidence for convertible forms of soluble uterine cyclic nucleotide phosphodiesterase.
Strada SJ; Epstein PM; Gardner EA; Thompson WJ; Stancel GM
Biochim Biophys Acta; 1981 Sep; 661(1):12-20. PubMed ID: 6271215
[TBL] [Abstract][Full Text] [Related]
31. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase activities of rat mammary tissue.
Mullaney I; Clegg RA
Biochem J; 1984 May; 219(3):801-9. PubMed ID: 6331397
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
Ilien B; Ruckstuhl M; Landry Y
J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
[TBL] [Abstract][Full Text] [Related]
33. [Effect of several hormones on cyclic 3',5'-nucleotide phosphodiesterase in rat kidneys].
Iwase K
Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1678-91. PubMed ID: 6319206
[TBL] [Abstract][Full Text] [Related]
34. 3':5'-cyclic-nucleotide phosphodiesterase in the bovine pituitary gland.
Nagasaka A; Ohkubo S; Hidaka H
Biochim Biophys Acta; 1983 Feb; 755(3):481-7. PubMed ID: 6297613
[TBL] [Abstract][Full Text] [Related]
35. Effects of Ca2+ and calmodulin on enzymes of cyclic nucleotide metabolism in ox neurohypophyseal secretosomes.
Dartt Da; Torp-Pedersen C; Thorn NA
Ann N Y Acad Sci; 1980; 356():369-70. PubMed ID: 6112949
[No Abstract] [Full Text] [Related]
36. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Souness JE; Diocee BK; Martin W; Moodie SA
Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
[TBL] [Abstract][Full Text] [Related]
37. Isolation, characterization and Ca2+ and calmodulin regulation of cyclic nucleotide phosphodiesterases from human placentae of different ages.
Tertrin-Clary C; Chenut MC; Acker G; De La Llosa P
Biochem Int; 1989 Jan; 18(1):99-117. PubMed ID: 2541726
[TBL] [Abstract][Full Text] [Related]
38. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
Elks ML; Manganiello VC
Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
[TBL] [Abstract][Full Text] [Related]
39. Regulation of cyclic nucleotide phosphodiesterase activity in rhesus fetal muscle.
Beatty CH; Herrington PT; Bocek RM
Biol Neonate; 1977; 32(1-2):33-42. PubMed ID: 198031
[TBL] [Abstract][Full Text] [Related]
40. Characterization of cyclic nucleotide phosphodiesterases in Xenopus laevis ovary.
Allende C; Plaza M
Comp Biochem Physiol B; 1987; 88(2):581-7. PubMed ID: 2827950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
